surmount-1 trial tirzepatide weight loss non-diabetic Demonstrates 94% Diabetes Reduction, 22% in SURMOUNT -1 Study surmount-1 tirzepatide non-diabetic obesity weight

**Energy industry professionals running on fumes.** The upstream oil and gas industry, petrochemical sector, and its adjacent professional services firms are known for punishing hours, especially during operational surges or project deadlines

In 2023, a global consortium of scientists, doctors and patients changed NAFLD to MASLD and NASH to MASH

People lose an average 8% of their starting weight in 56 weeks on the maintenance dose

Can Vegetarians Benefit More From L-Carnitine

Hunger and fullness regulation within your body becomes clearer through GLP-1 testing

Even though you're taking Wegovy for weight loss, you may still find yourself craving sugar